4-cyclopentene-1,3-dione

induces electrical excitability in crustacean muscle

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Pancreatic Neoplasms (Pancreatic Cancer) 03/11/2004 - "Secondly, as a further investigation of the promising power of this 4-cyclopentene-1,3-dione as an innovative pharmacophore, we discuss our strategy of development of hypoxia-targeting PTK inhibitor TX-1123 analogues, 2-nitroimidazole-aminomethylenecyclopentenediones, such as TX-2036, for cancer treatment, especially for pancreatic cancers, which have a high level of hypoxia."
2.	Neoplasms (Cancer) 03/11/2004 - "Secondly, as a further investigation of the promising power of this 4-cyclopentene-1,3-dione as an innovative pharmacophore, we discuss our strategy of development of hypoxia-targeting PTK inhibitor TX-1123 analogues, 2-nitroimidazole-aminomethylenecyclopentenediones, such as TX-2036, for cancer treatment, especially for pancreatic cancers, which have a high level of hypoxia."
3.	Carcinoma (Carcinomatosis) 10/07/2016 - "The cytotoxicity of benzo analogues and synthetic intermediates against cervical carcinoma HeLa cells shows the necessity of the 4-cyclopentene-1,3-dione moiety for biological activity."
4.	Hypoxia (Hypoxemia) 03/11/2004 - "Secondly, as a further investigation of the promising power of this 4-cyclopentene-1,3-dione as an innovative pharmacophore, we discuss our strategy of development of hypoxia-targeting PTK inhibitor TX-1123 analogues, 2-nitroimidazole-aminomethylenecyclopentenediones, such as TX-2036, for cancer treatment, especially for pancreatic cancers, which have a high level of hypoxia."

1.	2- hydroxyarylidene- 4- cyclopentene- 1,3- dione